Furthermore, our results showed that the RNA levels determined by EdgeSeq PIP aligned well with the protein levels determined by the IHC assessment of two important immunotherapy biomarkers, the fraction of PD-L1-positive tumor cells and CD8+ T cells. This evidence concerns the gene CD274 and neoplasm.